EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus

Robert T Brodell

Journal of the American Academy of Dermatology · 2026-09 · 95 (3) · 929

DOI: 10.1016/j.jaad.2026.06.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Robert T Brodell. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Brodell, R. T. (2026). JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus. Journal of the American Academy of Dermatology, 95(3), 929. https://doi.org/10.1016/j.jaad.2026.06.040

Vancouver

Brodell RT. JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus. Journal of the American Academy of Dermatology. 2026;95(3):929. doi:10.1016/j.jaad.2026.06.040

BibTeX
@article{Brodell2026,
  author = {Brodell, Robert T},
  title = {JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {3},
  pages = {929},
  doi = {10.1016/j.jaad.2026.06.040}
}
Kostenlos starten →